Release Summary

Vertex announces that the European Union Committee for Medicinal Products for Human Use issued positive opinions for ORKAMBI™ (lumacaftor/ivacaftor) and KALYDECO® (ivacaftor) in the European Union.

Vertex Pharmaceuticals Incorporated